Knowledge, attitude, perceptions and assessment of effectiveness of educational intervention on Pharmacovigilance among undergraduate medical students at Gulbarga Institute of Medical Sciences, Kalaburagi, India

Harish G. Bagewadi, Priyadarshini M. Deodurg, B. V. Patil, Asha P. Dass


Background: The Study was designed to assess the awareness of Pharmacovigilance and to evaluate the impact of an educational intervention.

Methods: This was a questionnaire-based pre- and post-test educational interventional study. Students were given handouts containing information about pharmacovigilance one month before the educational intervention. A pre-validated 20-point questionnaire on (KAP) Knowledge, attitude, perception about Pharmacovigilance was distributed to second year medical students (n=115). An interactive educational intervention (Power point presentation) was designed. The chi-square test and unpaired paired t-test was used for statistical calculation.

Results: The overall response rates were expressed as percentages, Mean±SD. The knowledge, attitude and perceptions of pharmacovigilance when compared before (pre-KAP) and after (post-KAP) the educational intervention, the correct response rates were found to be statistically significant (P<0.001). The feedback from the students was encouraging, handouts before the lecture classes helped them to easily grasp the pharmacovigilance concepts better during lectures.

Conclusions: The study concluded that imparting the knowledge about pharmacovigilance and ADR reporting promotes drug safety and rational use of medicines in future.


Attitude, Knowledge, Perceptions, Pharmacovigilance

Full Text:



Von Laue NC, Schwappach DL, Koeck CM. The epidemiology of preventable adverse drug events: a review of literature. Wien Klin Wochenschr, 2003;115(12):407-15.

Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. American Journal of Health System Pharmacy. 2003;60(3):253-9.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta analysis of prospective studies. J of the American Medical Association. 1998;279(15):1200-5.

Pirmohamed M, James S, Meakin S. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. British Medical J. 2004;329(7456):15-9.

Figueiras A, Tato F, Fontainas J, Gestal-Otero JJ. Influence of physicians’ attitudes on reporting adverse drug events: a case control study. Medical Care, 1999;37(8):809-14.

Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Irish J of Medical Science.1999;168:257-61.

Perlik F, Slanar O, Smid M, Petracek J. Attitude of Czech physicians to adverse drug reaction reporting, European Journal of Clinical Pharmacology. 2002;58:367-9.

Belton KJ, Lewis SC, Payne S, Rawlins MD. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, British J of Clinical Pha.1995;39:223-6.

Hasford J, Goettler M, Munter KH, Muller- Oerlinghausen B. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions, J of Clinical Epi. 2002;55:945-50.

Herdeiro MT, Figueiras A, Polo´ nia J, Gestal- Otero JJ. Physicians’ attitudes and adverse drug reaction reporting: a case control study in Portugal, Drug Saf, 2005;28:825-33.

Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy, Pharmacotherapy. 2004;24:1491-8.

Reddy VL. Assessment of Knowledge, Attitude and Perception of Pharmacovigilance and Adverse Drug Reaction (ADR) Reporting among the Pharmacy Students in South India. IOSR Journal of Pharmacy and Biological Sciences. 2014;9(2):34-43.

Radhakrishnan R, Vidyasagar S, Varma DM. An Educational Intervention to assess Knowledge Attitude Practice of pharmacovigilance among Health care professionals in an Indian tertiary care teaching hospital. Int J. Pharm Tech Res. 2011;3(2):678-92.

Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res. 1997;35:85-8.

Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296:1086-93.

Suveges LG, Gesy KF, Wallace SM, Blackburn JL, Appel WC. Adverse drug reaction reporting part II: evaluation of the Saskatchewan pilot project for a regional reporting program in Canada. Drug Information J.1995;29:581-9.

Scolt HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ, Green M, Andrews LG. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA. 1990;263:1785-8.

Chatterjee S, Lyle N, Ghosh S. A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf. 2006;29:641-2.

Bagewadi HG, Venkatadri TV, Nayaka SR. Impact of educational Intervention on Knowledge, attitude, Perceptions of Pharmacovigilance and adverse drug reactions in fifth term medical students and their feedback. Int J of Res. in Pharmacology & Pharmacotherapetics. 2015;4(2):164-74.

Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117:856-61.